- A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome
-
Lee JH, Ahn SG, Park B, Park SW, Kang YS, Lee JW, Youn YJ, Ahn MS, Kim JY, Yoo BS, Lee SH, Yoon J
- KMID: 2381560
- Korean J Intern Med.
- 2015 Sep;30(5):620-628.
- doi: 10.3904/kjim.2015.30.5.620
BACKGROUND/AIMS: Newer P2Y12 inhibitors, such as prasugrel and ticagrelor, have greater antiplatelet efficacy but may increase the risk of bleeding. In this study, we compared the pharmacodynamic efficacy of prasugrel... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of the Prevalence of Aspirin and Clopidogrel Resistances in Patients with Coronary Artery Disease by using Various Platelet-function Tests
-
Woo KS, Kim BR, Kim JE, Goh RY, Yu LH, Kim MH, Han JY
- KMID: 1022035
- Korean J Lab Med.
- 2010 Oct;30(5):460-468.
- doi: 10.3343/kjlm.2010.30.5.460
BACKGROUND: Dual therapy with aspirin and clopidogrel has emerged as the gold standard therapy for patients treated with drug-eluting stents (DES). However, there is variability in patients' responses to this... -
- CITED
-
- Close
- SHARE
-
- Close
